Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2017-06-21
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage

Sponsor
Sponsor

  WINDY CITY TIMES

Forum explores Truvada's use in fighting HIV
by Kate Sosin, Windy City Times
2011-06-22

facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email


When Gladstone Institutes released evidence that Truvada, a one-a-day HIV pill, might prevent HIV in addition to treating it, the news sparked both excitement and skepticism.

The AIDS Healthcare Foundation (AHF), the largest HIV/AIDS medical provider in the country, came out against the use of Truvada for prevention, despite the fact that Gladstone's Iniciativa Profilaxis Preexposicion (iPrEx) trial showed the drugs to be more than 90-percent effective in preventing HIV in those who took it daily.

Experts on the study sat down with Feast of Fun podcasters Fausto FernÃ"s and Marc Felion at Center on Halsted June 15 to talk about what the study means and if Truvada could signal the end of the pandemic. Present were Dr. Robert Grant of Gladstone Institute, Keith Green, director of federal affairs at AIDS Foundation of Chicago, and a youth who participated in a similar study Green conducted in Chicago.

"In our wildest dreams, we did not think [Truvada] would be more than 90-percent effective in those who took it," Grant told the audience.

The findings also astounded Green, who halted Project PrEPare, a similar Chicago study, because he didn't want to continue administering placebos when he knew Truvada worked.

While the effectiveness of Truvada in preventing HIV is clear, the practicality of it remains uncertain. For one, Truvada is meant to be taken daily, which could pose a challenge to many not accustomed to the routine or whose lives don't always allow for consistency, such as youth living on the street. Additionally, Truvada is not without side effects including nausea, although that tends to go away over prolonged use, said Grant.

One barrier in getting people to use Truvada is stigma, Grant said.

"These pills, in particular, have been the one thing that folks want to avoid," he said, adding that fear surrounding HIV/AIDS contributes to fear around taking Truvada for prevention. "It strikes people as a misuse [of the drug]."

The drug could cost as much at $10,000 a year, an impossibly high price for people without insurance. In Illinois, the AIDS Drug Assistance Program (ADAP) which provides antiretrovirals to those who cannot afford them, is already cash-strapped. Truvada used for prevention could compete with Truvada treatments, creating a kind of Catch-22 for service providers who want to end the spread of HIV but also serve those who are positive already.

"We really have an ethical dilemma," Green said.

Still, many insurance companies are interested in Truvada for prevention because even with the cost of the drug, prevention is at least half the cost of treatment.

Rico, the youth who participated in Green's Chicago study on Truvada said that taking the drug made him "more considerate" of his body and protecting himself. He said that he had been hesitant to participate in the study but decided to sign up when he learned of the impact it could have on his community.

Grant and Green did acknowledge that iPrEx study had its shortcomings.

"I started to look at Dr. Grant's work, and those people didn't look like our people," Green said, adding that a low number of youth and African Americans had participated. Grant agreed and noted that their efforts would seek the expertise of Chicago service providers whose work included a diversity of clients. Still he added, the drug seemed to work equally well among people of every race.

As for AHF's critiques of using Truvada for prevention, neither Grant nor Green seemed to give them much weight.

"This is a large corporation, actually that has revenues above 300 million dollars a year, so well above my pay grade," said Grant, who went on to say that he was not certain about why AHF was working to discredit the trial results.

Truvada is awaiting FDA approval before it can be marketed for HIV prevention. Grant said that Gilead, the company that makes Truvada, will likely be hesitant to market the drug for prevention and that it will be up to AIDS service providers to make the leap in making Truvada more accessible.

For some, that leap can't come quickly enough.

"We either pay now or we pay forever," Grant said. "We have a chance now to stop this epidemic."


facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

LGBT advocates and allies denounce Senate health care plan 2017-06-23
HRC Opposes Senate GOP Proposal to Rip Health Coverage from Millions 2017-06-22
UIC launches injectable PrEP study 2017-06-21
Kathy Bates to headline Oct. 2 event 2017-06-21
TPAN returns to Edgewater location 2017-06-21
John Hassey rises up for the role of a lifetime 2017-06-21
Howard Brown expands program for assault survivors 2017-06-21
Social worker to be honored as leader 2017-06-21
Johnson among Gilead recipients 2017-06-21
Health experts call for better management during drug shortage 2017-06-21
Youth Outlook to honor Garofalo 2017-06-21
Psychologist talks sexual orientation, LGBQ-affirmative therapy 2017-06-21
Remembering NAMES 2017-06-21
Registration open for AIDS Run & Walk 2017-06-21
Pier Pride at Navy Pier to host AIDS Memorial Quilt, full day of Pride events 2017-06-21
National roundup: Blood-donor campaign, trans win in Va., Calif. honorees 2017-06-20
FAIRY GARDENER, planning and surprises 2017-06-20
HIV/AIDS Council members resign after Trump inaction 2017-06-19
Windy City Times Job Fair Sept. 22 at Center on Halsted 2017-06-17
AMA adopts policies supporting transgender and LGB health, GLMA responds 2017-06-17
Windy City Times Job Fair Sept. 22 at Center on Halsted 2017-06-17
Museum event on science of sex June 20 2017-06-16
FDA okays generic Truvada configuration 2017-06-14
TPAN open house to showcase new office, partnership with Howard Brown 2017-06-13
Underwear for periods, not gender, launches in Chicago 2017-06-13
NCAVP hate violence report: 2016 deadliest on record for LGBTQ, HIV communities 2017-06-12
Howard Brown Health Heads to Washington, DC in support of the Equality Act 2017-06-09
Kathy Bates to speak at Lynn Sage Cancer Research Foundation Annual Fall Benefit 2017-06-08
Abstinence-only leader in key Department of Health and Human Services job 2017-06-07
Field Museum scientists at Sidetrack to discuss nature's variety of sexual behavior 2017-06-07
Sweets & Snacks Expo mixes indulgent and healthful 2017-06-06
NYC memorial event to honor journalists who died of AIDS or covered the epidemic 2017-06-06
Amit Paley Named as The Trevor Project's CEO 2017-06-06
Proposal to gut ACA contraceptive rule puts women's health in employers' hands 2017-06-01
Patrick Dati raises voice against domestic abuse 2017-05-31
National roundup: Stephen Colbert, '30 Days of HIV,' drag-queen death 2017-05-30
World news: InterPride, HIV death warning, tennis icons clash 2017-05-30
Transgender persons more likely than non- to lack health insurance 2017-05-30
Every Child Deserves a Family (ECDF) Act of 2017 introduced 2017-05-30
Burgess re-elected to exec committee 2017-05-30
 



Copyright © 2017 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor


 



Sponsor

About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Submit an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.